These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 4604882)

  • 21. [Treatment of common rheumatoid polyarthritis with D-penicillamine. Study of a series of 22 cases].
    Lièvre JA; Camus JP; Bénichou C; Guillien P; Crouzet J
    Ann Med Interne (Paris); 1971 May; 122(5):655-62. PubMed ID: 5563719
    [No Abstract]   [Full Text] [Related]  

  • 22. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of rheumatoid arthritis with D penicillamine].
    Vanslype J; Tritsmans E; Verstraeten J
    J Belge Rhumatol Med Phys; 1975; 30(2):108-13. PubMed ID: 1230462
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of D-penicillamine treatment on the humoral immune system.
    Stanworth DR; Hunneyball IM
    Scand J Rheumatol Suppl; 1979; (28):37-46. PubMed ID: 287190
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical experiences with d-penicillamine in rheumatoid arthritis (author's transl)].
    Saxer M; Oeding A; Kaganas G; Vogt E
    Schweiz Rundsch Med Prax; 1977 Feb; 66(8):240-6. PubMed ID: 840828
    [No Abstract]   [Full Text] [Related]  

  • 26. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experiences with D-penicillamine with chronic polyarthritis].
    Mathies H; Schötz H; Schuh M
    Med Klin; 1970 Oct; 65(44):1929-33. PubMed ID: 5480422
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.
    Dixon AJ; Davies J; Dormandy TL; Hamilton EB; Holt PJ; Mason RM; Thompson M; Weber JC; Zutshi DW
    Ann Rheum Dis; 1975 Oct; 34(5):416-21. PubMed ID: 769707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of D-penicillamine for the treatment of rheumatoid arthritis by a double blind test].
    Shiokawa Y; Horiuchi T; Honma M; Kageyama T; Okada T
    Ryumachi; 1977 Mar; 17(2):205-10. PubMed ID: 325668
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of common rheumatoid polyarthritis with D-penicillamine].
    Camus JP; Bénichou C; Guillien P; Crouzet J; Lièvre JA
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):809-20. PubMed ID: 5152714
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of chloroquine and D-penicillamine in the treatment of rheumatoid arthritis.
    Muirden KD
    Med J Aust; 1986 Jan; 144(1):32-4, 36-7. PubMed ID: 2867456
    [No Abstract]   [Full Text] [Related]  

  • 33. Observations on the treatment of rheumatoid disease with penicillamine.
    Golding JR; Wilson JV; Day AT
    Postgrad Med J; 1970 Oct; 46(540):599-605. PubMed ID: 5488219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and toxicity of D-penicillamine for rheumatoid disease in the elderly.
    Kean WF; Anastassiades TP; Dwosh IL; Ford PM; Kelly WG; Dok CM
    J Am Geriatr Soc; 1982 Feb; 30(2):94-100. PubMed ID: 6460054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity of penicillamine. A serious limitation to therapy in rheumatoid arthritis.
    Halverson PB; Kozin F; Bernhard GC; Goldman AL
    JAMA; 1978 Oct; 240(17):1870-2. PubMed ID: 691197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating immune complexes in patients with rheumatoid arthritis and the effect of penicillamine in vitro.
    Crawhall JC
    Clin Invest Med; 1984; 7(1):53-8. PubMed ID: 6723125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic studies of D-penicillamine in the treatment of rheumatoid arthritis.
    Payne RW; Cahill CL
    J Okla State Med Assoc; 1969 Oct; 62(10):487-91. PubMed ID: 5406880
    [No Abstract]   [Full Text] [Related]  

  • 38. Proceedings: Penicillamine or gold for rheumatoid arthritis? Multicentre trial using 'blind' observers. The first six months.
    Huskisson EC; Gibson TJ; Balme HW; Berry H; Burry HC; Grahame R; Hart FD; Henderson DR; Wojtulewski JA
    Ann Rheum Dis; 1974 Jul; 33(4):399. PubMed ID: 4606941
    [No Abstract]   [Full Text] [Related]  

  • 39. IgG and IgM rheumatoid factors in rheumatoid arthritis. Quantitative response to penicillamine therapy and relationship to disease activity.
    Wernick R; Merryman P; Jaffe I; Ziff M
    Arthritis Rheum; 1983 May; 26(5):593-8. PubMed ID: 6847722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of rheumatoid arthritis with D-penicillamine].
    Miehlke K
    Arzneimittelforschung; 1971 Nov; 21(11):1815-7. PubMed ID: 5171812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.